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Allergic and atopic diseases associated with abnormalities in IgEproduction may
represent the most frequent immunological disorders. However, the IgE response
and its regulation, the normal role ofreaginic Igs, and underlying reasons for the
high incidence ofabnormal IgE responses are not fully understood. In normal pe-
ripheral blood, IgE-committed B lymphocytes are rare. Reported frequencies range
from 1 in 3-5 x 103 to as low as one in 105 B cells (1-3). While the low frequency
ofIgE-committed cells is mirrored in low (ng/ml) IgE serum levels, the biological
effectiveness ofIgE is considerable. After IgE binding to the receptor for the Fc re-
gion ofthe IgE molecule (FcERI)' on mast cells and basophils (4), the crosslinking
ofcell-bound IgE by allergen causes releaseofhistamine, kinins, and otherproducts
ofcell stimulation. This, in turn, leads to allergic reactionsthat can includeanaphylaxis
and death (4).
Theeffectiveness ofIgE inthis processderivesfrom the high affinity ofFCCRbinding
(Kd, 109 M- '). High affinity FceRs are able to bind IgE at 10,000-fold lower con-
centrations than Fcy receptors on monocytes can bind IgG (reviewed in reference
5). More recently, a second class ofrelated but distinct FceRs has been identified.
In contrast to FcERI, the binding of IgE to this low affinity FceR (FceRII) is closer
in affinity to FcyR/IgG binding. Cell-bound and soluble FceRII-related molecules
are presently thought to play a role in the regulation ofe gene expression. However,
FceRII is expressed by several different cell lineages and it remains unclear exactly
where and how the expected IgE isotype specificity in regulation is conferred and
where and how this process fails in atopy or allergy.
Considerable progress has been made in delineating regulatory T cell functions
that govern IgE responses in parasite-infected animals andthose in normal or atopic
humans (6, 7). Products ofcertain T cell lines/clones were found to alter IgE gene
expression. These cells often express low affinity FceRs and produce IgE-binding
factors that either suppress or enhance IgE secretory rates, typically in myeloma
lines or fresh B cells (8-10). Similar regulatory activities have been detected in T
cells from normal and atopic donors (11-13). Some of the regulatory molecules in-
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volved have now been molecularly cloned and shown to be analogous to a region
of the FcER (14).
As the source of reaginic Ig molecules, the B cells committed to IgE secretion
must play a central role in the allergic response. Understanding the differentiation
pathway that generates IgE-producing cellsmay be as important to our understanding
of allergy as the study of cells at the end of this developmental pathway. With much
work focusing on T cell effects and on terminally differentiated IgE-secreting my-
eloma cell lines, relatively little information is available that characterizes the IgE-
committed B cell sublineage.
Investigations of the IgE-producing B cells themselves have been hindered not
only by their low frequency but by the difficulty to activate and propagate them in
vitro. Standard culture systems have proven unsatisfactory in generating reasonable
numbers of progeny cellsor cell lines (15, 16). However, we and others (2, 3) success-
fully activated similar frequencies of IgE-secreting cells in limiting dilution culture
systems supplemented with allo-activated T cells or after infection with EBV. These
low density cultures have a much higher efficiency than do mass cultures and they
reduce suppressive cell interactions that interfere with IgE responses (17, 18) .
The use of EBV in this system previously allowed us to generate one stable IgE-
secreting clone (KlD5) that unexpectedly produced IgM in addition to IgE and that
appeared not to have deleted DNA between VDJ (variable/diversity/joining regions)
Ct, and CE constant region genes (3, 12, 19). This contrasts with the prototype human
IgE-secreting cell line, the myeloma U266, which produces only IgE and has dele-
tionally rearranged VDJ in an isotype switch from C/A to CE (20). In the experi-
ments described here, we asked whether the KID5 line was a rare or atypical cell
in the differentiation pathway of IgE-committed B lymphocytes or whether it repre-
sented a normal member of this B cell subset and the pathway itself was in some
way distinct from that of other isotypes.
During normal B cell differentiation, cells first express IgM on their surface and
then become cell surface Ig' (sIgM'/sIgD+ ). Upon antigen activation some cells
then switch to the production of other isotypes, most commonly IgG. This H chain
switch usually involves transposition of the active V region (VDJ[H]) gene from the
expressed CI to one of the other constant region genes (21). The exception is IgD,
where there is no functional switch region immediately 5' of C6 (22).
While this mechanism usually guarantees that a given B cell produces only a single
isotype or subclass, there have been rare observations of double isotype production
in (rodent) B cells. Yaoita et al. (23) detected surface it' /E' mouse spleen cells by
cell sorting. LaFrenz et al. (24) sorted surface IgG' cells that were shown to later
secrete IgM. Sandwich RNA hybridization studies by Perlmutter and Gilbert (25)
suggested a low frequency occurrence of nuclear RNA containing both 1. and 'Y or
a gene regions in sorted memory cell populations, and a subclone ofthe mouse lym-
phoma line BCL, was shown by Chen et al. (26) to cosecrete IgM and IgGl.
In fluorescent staining experiments, it is difficult to always ascertain that only en-
dogenously synthesized and not cytophilic Ig is detected (27). Nevertheless, these
studies suggest that double isotype production can occur in at least some cells, albeit
rarely (28-31). Such findings can be accommodated by two alternative models. (a)
Perhaps in the process of H chain switch, cells pass normally through a double ex-
pression stage but do so very quickly, and therefore remain undetected. (b) All BMACKENZIE AND DOSCH
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cells may be inherently capable of double isotype production but it occurs only on
rare occasions, perhaps accidentally (32-34) .
In the present study of B cells from normal donors, we have combined cell sorting,
EBVinduced transformation, cloning, and molecular genetics techniques to distin-
guish these two alternatives in the IgE system . Our observations suggest that the
coexpression of IgE plus IgM and IgD is the rule in this B cell sublineage . IgE-
secreting EBV responders expressed sIgM and sIgD before and after transforma-
tion, i.e., during cell sorting, throughout culture and cloning procedures . This was
reflected in the genome of IgE-secreting clones as a rearrangement ofVDJ to CA
and the retention of all three f genes in germline configuration . The isotype switch
typical ofmyeloma lines like U266 (20), thus, does not occur in these B lymphoid
cells, despite the presence ofnormal sized e (as well as p,) mRNA . In contrast, in
this and other laboratories (35-37), double isotype production was never detected
in EBVtransformed IgG and IgA producers, all ofwhich show genomic rearrange-
ment ofVDJ to the IgH locus expressed . It therefore appears that IgE-committed
B cells regularly reach a stage of multiple isotype expression as a characteristic and
stable rather than transient phase in their ontogeny . Although multiple isotype ex-
pressionmay rarely occur in IgG and IgA producers (24, 31), we favor a modelwhere
IgE-committed B cells represent a unique B cell subset and perhaps travel a distinct
differentiation pathway where deletional switch rearrangement occurs only rarely
and late in development .
Materials and Methods
CellPreparations .
￿
PBMC from normal donors were purified on Ficoll-Hypaque gradients,
washed and resuspended in RPMI 1640 (Ontario Cancer Institute, Toronto), and supplemented
with 10% FCS (HyClone Laboratories, Logan, UT), antibiotics, L-glutamine, and 50 AM
2-ME . Where indicated, B cells were enriched by E-rosette depletion (17) . Peripheral blood
polymorphonuclear cells were enriched by Plasmagel' sedimentation and extracted as a source
of germline DNA .
Cytofluorometry and Reagents .
￿
PBMC were stained with monoclonal (mouse) or affinity-
purified polyclonal (goat) antibodies against differenthuman Ig isotypes (Coulter Electronics,
Inc ., Hialeah, FL or BioCan Laboratories, Mississauga, Ont .) . Monoclonal anti-IgE(Fc) an-
tibodies were a gift from Dr . A . Saxon (UCLA) (38) . Indirect stains were visualized with
fluoresceinated, affinity-purified, goat anti-mouse Ig antibody. Mouse Igs of the same sub-
class were used as controls . Stained cells were washed with PBS, resuspended in RPMI, and
analyzed in anEPICSV cytofluorometer (Coulter Electronics, Inc.) . Propidium iodide (PI)
was added to exclude nonviable cells from analysis . For culture, individual fluorescence-positive
or -negative cells were seeded directly into microwells using an Autoclone" attachment to
the cell sorter equipped with a custom log increment EPROM (Coulter Electronics, Inc .)
as described (39, 40) . Rhodaminated goat anti-human IgM and goat anti-mouse Ig for cyto-
plasmic double-staining experiments were obtained from BioCan Laboratories .
Cytoplasmic Staining .
￿
The coexpression ofcytoplasmic Igs was examined by immunofluores-
cent double staining (41) . Briefly, cytocentrifuge cell preparations (cytosmears) were fixed
in cold alcohol/glacial acetic acid (95:5) and stained (45 min, 22 °C) in ahumid atmosphere
in the dark . For direct staining, rhodaminated antibody against one Ig and fluorescein-
conjugated antibody against a second Ig were used . For unconjugated mAbs, a secondary,
fluorescence-labeled goat anti-mouse Ig was used (BioCan Laboratories) . Smears were
preserved in 90% glycerol and examined in an epifluorescence photomicroscope (Carl Zeiss,
Inc ., Thornwood, NY) .
Virus Preparation and Infection .
￿
The purification of EBV has been described (40) . Briefly,
supernatants of the B95-8 marmoset line were filtered, washed and concentrated 100-fold410
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by ultracentrifugation, and stored at -70°C. Virus infectivity was estimated by the ability
of diluted virus stock to induce cell growth and IgM production in 4-wk cultures of 104 cord
blood lymphocytes. B cells were infected either in bulk or by addition of 20 A1 oftitered virus
(30-fold excess) to limiting dilution cultures. In the former procedure, 1-5 x 106 PBMC were
infected with 500 ul of virus (2 h, 37°C) and used for culture after washing.
Culture Conditions.
￿
Limiting dilution cultures were seeded manually or with the Autoclone'".
In manual preparations, EBV bulk-infected cells were diluted in complete medium and added
to 96-well, microtiter plates (Costar, Cambridge, MA) containing 104 irradiated (3,000 rad)
DT1.2 cells, a human T-T hybridoma line selected in our laboratory for its ability to support
low density B cell cultures (42). In some experiments, 3 x 104 irradiated, PHA-activated
cord blood lymphocytes were used as feeder cells with similar results. 46 replicates of typi-
cally eight cell doses (10-10,000/well) were fed weekly with 130 j1 fresh medium. Week five
supernatants were stored frozen until tested by ELISA. Cultures containing >1 ng/ml of a
given Ig were considered positive for that isotype (40). Growth transformation was scored
microscopically at week five. Control cultures without donor lymphocytes, EBV, or in the
presence of cycloheximide were always negative for growth and secretion.
Sublining and Cloning Procedures.
￿
IgE-producing lines from individual fifth-week culture
wells were expanded to -105 cells/ml in 25-cm2 flasks (Costar) . Sublining was performed
twice by transferring 1-3 % of cells into 24-well culture plates and expansion for 3-4 wk (43).
Clones were established by limiting dilution in the presence of DT1 .2 feeder cells (44). Sub-
cloning utilized the Autoclone" to place single, PI- cells, unstained, or brightly or weakly
staining for sIgM into microtiter wells. All cell lines and clones reported had a normal karyotype.
ELISA.
￿
Ig secretion was measured by ELISA as described (40). Briefly, Linbro EIA 96-
well microplates (FlowLabs, Mississauga, Ont.) were coated at 4°C with anti-Ig, blocked
with 0.17o BSA, (Sigma Chemical Co., St. Louis, MO), washed, and 10-30 ill ofsample was
added in 0.1 M Tris-HCL containing 2 mM Ca2l, Mg", Zn", and 0.170 BSA. After over-
night incubation and washing, anti-Ig conjugated to alkaline phosphatase (BioCan) was added
for 2 h. After washing, bound enzyme activity was measured with 0.8 mg/ml p-nitrophenyl
phosphate as a substrate. The optical density (OD41o) was read in a Dynatech MR600"
ELISA reader (Fisher Scientific, Toronto) connected via an Apple'" microcomputer to a UNIX
VAX'" system for statistical analysis and quantitation.
StatisticalAnalysis.
￿
Our criteria for the analysis of limiting dilution experiments have been
reported (17, 39, 40). Frequencies were determined by both maximum likelihood (ML) and
minimum X2 (MCS) methods with UNIX software developed along the arguments of Taswell
(3, 45). Single-hit kinetics were assumed at probabilities ofp > 0.1 and where y-axis inter-
cepts of regression lines were close to zero. In all experiments reported the results determined
by ML and MCS differed by <107o. The expected coincidence of two independent events
(i.e., the presence oftwo unrelated clones in a given culture well) was determined by frequency-
based contingency analysis and probabilities were estimated using Fisher's exact test (17, 46).
DNAProbes.
￿
Plasmids were routinely purified by equilibrium banding in cesium chloride
gradients (47). Excised inserts were isolated by electroelution from agarose gels. The plasmids,
pHujC, pHuEC, pHuaC(GMA-5a1), and pHuJ(H), were obtained from Dr. P. Leder (Har-
vard University, Boston, MA). The M1361 clone was a gift of Dr. T H. Rabbitts (MRC
Laboratory, Cambridge, UK). We subcloned a 240-bp segment into puc-19 (pbl).
TheJ(H) probe was excised from pHuJ(H) as a 6-kb Barn HI/Hind III fragment spanning
all J regions and the H chain enhancer (48). The C/, probe includes exons 1, 2, and part
of 3 of the constant region gene, and is a 1.5-kb Eco RI/Eco RI insert of pHuuC (48). The
e probe encodes all four e constant region exons, and is a 2.6-kb Barn HI/Bam HI fragment
from pHuEC (49). An Xho I/Bam HI Ca, fragment of pHuceC(GMA-5a,), 4.6 kb in length,
crosshybridizes with Cal and Cat (50). The 6 probe includes both a hinge exon and intron
(51) . 50-100 ng of probes were labeled with a[32P]dCTP by random priming (52), and all
showed sp act of >5 x 10s cpm/j.g.
Southern Hybridization.
￿
DNA was extracted from polymorphonuclear cells and cell lines
according to Davis et al. (53). After digestion with restriction endonucleases (Boehringer Mann-
heim, Mannheim, FRG), 10 lsg DNA was applied to 0.670 agarose gels. Gels were blotted
according to Southern (54) onto nylon membranes (ICN Biomedicals, Irvine, CA). Hybridi-MACKENZIE AND DOSCH
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zations were carried out overnight at 42°C in 50% formamide, 5X SSC, Denhardt's solution
(0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% BSA), 100 Wg/ml salmon sperm DNA,
and specific probe. Hybridization was followed by two, 30-min room temperature washes
in 3X SSC and two 20-30-min washes at 65'C in 0.3X SSC. Autoradiographs were devel-
oped aftertypically 3-7 d exposure at -80'C, to x-ray film (XAR5; Eastman Kodak, Roch-
ester, NY) in the presence of intensifying screens. For repeated hybridizations, blots were
stripped for 1-4 h at 65'C in 5 mM Tris containing 10 mM EDTA and pyrophosphate.
Northern BlotAnalysis.
￿
Total RNA was isolated by the acid guanidinium thiocyanate-phenol
chloroform extraction protocol (55). To enhance the yield of specific RNA transcripts, some
cultures were exposed (12 h, 37°C) to cycloheximide (100 hg/ml) (56). Poly(A)` RNA was
prepared from the RNA of IgE/M/D-secreting transformed clones by oligo-dT-cellulose chro-
matography. For Northern blots, 2 or 20 kg of pooled poly(A)' RNA was separated in 1%
agarose gels containing 6% formaldehyde in a 1X MOPS running buffer (0.02 M MOPS
[3-[N-Morpholino]propane-sulfonic acid] 5 mM Na Acetate, 0.1 mM EDTA). RNA (10 Fig)
from the human myeloma cell line U266 was used as a control (20). The samples were sub-
jected to electrophoresis 4 h at 150 V. Ethidium bromide staining identified 23S and 16S
bacterial rRNA and 28S and 18S eukaryotic rRNA molecular weight markers. RNA was
transferred to nitrocellulose and hybridized overnight in 50% formamide, 5X SSC, Den-
hardt's solution, 50 Fig/ml salmon sperm DNA, and specific probe. Four 5-min room temper-
ature washes in 2X SSC were followed by a 1-h 65'C wash . After hybridization, autoradio-
graphs were developed after after a 2-d exposure at -80'C with the k probe and 10-14 d
after hybridization with the e probe.
Results
Frequency ofEBV-responsive B Cells.
￿
Limiting dilution assays permit quantitative
analyses of the clonal heterogeneity and isotype diversity among B cells susceptible
to the virus (reviewed in reference 40). With minimal uncontrolled, suppressive cell
interactions, the efficiency of EBVinduced B cell activation and transformation in
these cultures is N30-100-fold higher than that observed in bulk cultures and with
other human B cell activators, reaching as high as >30% of B cells responding (18,
36). Lymphocytes committed to IgE secretion are, in our hands, detected only in
such limiting dilution cultures of EBVinfected cells (3). Fig. 1 shows results of two
typical limiting dilution experiments with PBMC from normal, healthy donors. Fresh
cells were bulk infected with EBV and seeded into limiting dilution cultures. Week
five supernatants containing >1 ng Ig/ml were considered positive for that isotype.
Most Ig' wells (>90%) also scored positive for cell growth at this time. The inci-
dence of EBV responders (per B cell seeded, one/frequency) was determined as the
cell dose where 37% of cultures were negative (17, 45).
Underour culture conditions, frequencies ofEBVresponsive Ig secretors fall within
typical ranges (36, 40). As shown in Fig. 1, IgM was the most common isotype de-
tected with one responder in 20-60 B cells seeded. Approximately 5-10% of IgM
secretors coproduced IgD and cultures secreting IgD alone were not observed. IgA
and IgG were detected in nearly equal frequencies, ranging from 1 in 60 to 1 in
120 B cells. IgE secretors represent a small but distinct and consistently measurable
entity whose frequency averaged 1 in 1,500 B cells in these experiments (range
1 :800-1 :3000). Overall culture efficiencies (-5-10% of B cells responding) were
similar in the experiments described in this report.
Phenotype ofIgE-committed B Cells.
￿
To characterize the phenotype of IgE-committed
cells, we combined cell sorting and autocloning of fresh PBMC stained for various
Ig classes (39, 40). Infection with EBV and limiting dilution analysis were then used41 2
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FIGURE 1 .
￿
Limiting dilution analysis of PBMC. Cells were incubated with EBVand cultured
5 wk when Ig secretion was determined by ELISA. Thefraction of cells negative (<1 ng Ig/ml)
foreach measured isotype is plotted on the ordinate, vs. the number of B cells added per well.
Probability values ofp > 0.1 confirm that cultures follow single-hit kinetics where only one vari-
able (the number of B cells seeded) was limiting the response, i.e., Ig secretion. Shown are two
representative experiments of seven performed. A, IgM; B, IgD; C, IgG (open symbols) and IgA
(closed symbols); D, IgE.
to measure the frequency of IgE producers derived from positively or negatively
selected populations.
We first determined the fidelity of this approach by staining PBMC with anti-Ic
or anti-A L chain antibodies. An average of one in seven B cells that were sorted
for the expression of either surface K or X were growth transformed in these experi-
ments. Virtually all cultures positive for K secretion were found in the populations
sorted as either a' or X- , while nearly all X secretors had been selected as X' or
K_ . Transformation rates ranged from 1:7 to 1:12 B cells seeded in either popula-
tion. Thefrequency of crosscontaminating cellsranged from 1:4,500 to 1 :5,200 cells
seeded. This indicated that our experimental approach was capable of >98% dis-
crimination (data not shown).
PBMC were stained for sIgM or sIgE and positive or negative fractions were au-
tocloned into limiting dilution cultures. In the example shown (Fig. 2 A), sIgM+
cells represented 9% of the PBMC population. At most, 1% of cells stained weakly
sIgE' (Fig. 2 B). Frequency estimates of IgE secretors after 5 wk of culture showed
that >90% of IgE-producing cells had been sorted with the sIgM' population, while
<10% had been sorted as sIgM- (Fig. 2 Q. Surprisingly, cells sorted as sIgE' con-
tained <30% of the IgE-secreting B cells, while more than two thirds of all such
cells detected were found in cultures of sIgE- lymphocytes. This suggested that IgE-
committed B cellsexpressed sIgM, butnot necessarily detectable sIgE, before EBV
infection and culture.FIGURE 2.
￿
Fluorescence histogram ofPBMC stainedwith anti-IgM or anti-IgE antibody. Posi-
tive and negative cells were selected in autocloning experiments as indicated . (A, IgM; B, IgE) .
(C)Phenotype of transformable IgE producers . The proportions ofIgE-committed B cells were
determined from the frequency ofgrowing IgE producers in each sorted population after 5 wk
of culture .
To further define the phenotype of cells giving rise to IgE-secreting clones in cul-
ture, enriched B cells were stained and selected for other Ig isotypes as well . Cells
were autocloned into microtiter wells as described in Fig . 2 . The culture efficiency
was estimated usingcontrol cultures of'sham-sorted' cells, stained for sIg, but selected
with open gates in the cell sorter (40). In the experiment shown in Table I, the cul-
I
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TABLE I
Precursor Cell Phenotype of EBV-responsive IgE Producers
Enriched B cells were sorted as indicated . Cells positive or negative foragiven
isotype were seeded into limiting dilution microcultures, infected with EBV,
and secretion of all Ig isotypes wasanalyzed after 5wk ofculture . Frequencies
of responding cells were determined using Poisson statistics . Limiting dilu-
tion cultures of sham-sorted cells (stained but not gated) provided a control
and measure of overall culture efficiency .
Cells secreting any Ig isotype .
Cells secreting IgE.
1/frequency = Number of B cells seeded that contain an average of one
responder cell .
Only two cell doses were available for analysis .
Phenotype of
selected cells All EBV responders`
1/frequencey4
IgE producersl
1/frequency§
Sham sorted 1 :22 1 :1,820
slgM' 1 :6 1:810
sIgm- 1 :130 <1 :10,000
slgD' 1:9 1 :810
slgD - 1:180 <1 :10,000
sIgE' 1:3,0000 1 :3,900 0
sIgE - 1:20 1 :1,740
sIgG' or sIgA' 1:110 <1:10,000
sIgG - or sIgA - 1 :17 1 :1,68041 4
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ture efficiency was 4 .5% with one responding cell in every 22 cells seeded . Frequen-
cies of B cells secreting any Ig and those secreting IgE are compared in the table.
Most circulating B cells are sIgM'/sIgD' , as are the majority of EBVtransform-
able cells (18, 36). This was confirmed in these experiments by the precursor cell
frequencies obtained for the different isotypes. Selection of sIgM + cells before cul-
ture resulted in an enrichment ofboth the numbers of EBV responders overall, and
the numbers of IgE producers. Conversely, the sIgM- population was depleted of
both. Similar results were obtained after selection of sIgD' cells, indicating that
the majority of IgE-committed B cells are sIgM' /sIgD' before EBV transforma-
tion. Again, few IgE producers expressed detectable sIgE before culture. Cells selected
as sIgE+ would include FccR' cells, which bind cytophilic IgE on the surface but
are not related to the IgE-committed sublineage (27). The incidence of IgE-committed
cells in sIgG' /sIgA' populations was below confidence limits established by L chain
gating experiments and rare IgE-producing cells in these cultures may reflect cross-
contaminating sIgM' cells. Slight discrepancies in the frequencies of EBV
responders in IgG- /IgA- and IgM'/IgD' populations may reflect an enrichment
of contaminating non-B cells in the negatively selected population.
The phenotype ofcells that give rise to IgE-secreting clones in our culture system
appear to be over two thirds sIgM' /sIgD' /sIgE- , with the remainder sIgM' /
sIgD'/sIgE' . This phenotype is similar to the IgE/IgM-coproducing KID5 clone
(3, 11, 19) and in this respect the clone does not appear to be a rare exception among
EBVresponsive IgE producers.
Coincidence of IgE. IgM, and IgD Production.
￿
B cell clones producing a given iso-
type should be independent and thus randomly distributed in our cultures (18, 44).
We analyzed limiting dilution culture wells for all Ig isotypes secreted to determine
the coincidence of IgE secretion with any other isotypes. At cell doses where 37%
of replicate cultures are negative for a given isotype (in the case of IgE secretion,
"1,500 B cells), each positive well receives an average of one precursor cell able to
proliferate and secrete that isotype (46). The chance that a given well receives more
than one precursor is described by Poisson: if D is the number of B cells seeded,
and f the precursor cell frequency, then the probability (P) for the presence of n
precursors is Pn (DJ) = (Df)° x e- °fin (reviewed in reference 17).
For coincidence analysis, we arbitrarily chose relatively small B cell inputs of 200
or fewer per well and calculated the probability for the coincidence of two (n = 2)
IgE-producing clones to be present in these cultures. In one series of experiments,
altogether, 1,012 cultures received 200 or less B cellsand these yielded 30 IgE-producing
clones. Given the average frequency of IgE-committed cells (6.67 x 10-4 or 1 :1,500),
the probability for the coincidence of two independent clones was P = 0.01. This
indicated that <1 of 100 IgE' cultures was not clonal with respect to IgE-producing
cells.
The random chance for two independent clones producing any isotype to be present
in the same well is a function of their respective frequency (17, 46). We assumed
that B cells are distributed independently and that a given B cell is committed to
the production of only one isotype. Since the frequency of, for example, IgM-
committed cells is much higher than that of IgE producers (Fig. 1), some IgE' wells
should contain otherclone(s), in particular those secreting IgM . The expected number
of IgE-secreting cultures containing an IgM- or IgD-secreting clone was estimatedMACKENZIE AND DOSCH
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by contingency analysis (46) . Of the 30 wellspositive for IgE, <15 could be expected
to containan IgMsecretor,<2 ofwhich might produceIgDas well . Observednumbers
were 29 IgM/IgEand 30 IgD/IgE-producing wells . Fisher's exact test indicated that
the observed coproduction reflected closely linked anddependent events (p < 0.05) .
Fig. 3 illustrates isotype expression in 79 IgE positive limiting dilution cultures
seeded with 20-2,000 cells. At higher cell inputs more wells contained multiple clones
ofcell secretingan Ig isotypeotherthan IgE . However, at low cell densities IgG- and
IgA-producing cells were diluted out, whileIgM and IgD production remained un-
changed . In seven experiments not a single IgE+ well failed to also secrete IgM
and/or IgD and in <2% of cultures, was either isotype (but not both) at or below
our detection limits . The distribution of IgG and IgA secretors was entirely inde-
pendent ofIgE secretion in all experiments (data not shown) . Furthermore, in each
IgE-producing culture, IgM, IgD, and IgE expressed the same L chain, while IgG
and IgA showed the expected (N6 :4) K/A diversity. Secretory data obtained after 5
wk o£ growth in culture, as well as the results of sorting data, all suggested that IgM
and IgD are continuously coexpressed by virtually all IgE secretors .
Subliningand Cloning ofIgE{ Cultures .
￿
It was conceivable that in each individual
limiting dilution culture a clone secreting only IgE was present that required the
presence of an IgM' /IgD+ clone for transformation or growth . To examine this pos-
sibility, we used sublining and cloning experiments of IgE' limiting dilution cul-
tures . In five different experiments a total of 18 primary cultures were expanded
without change in secretory patterns . Of these, nine were sublined at least twice
(see Materials and Methods) . Contaminatingclones secretingIgG or IgAwere quickly
separated from IgE-secreting clones in the same line and discarded (Fig . 4) . Subse-
quent formal cloning experiments generated many IgM/D/E producers but failed
to derive even one single (e.g ., IgE - ) or double (e.g ., IgM/D- ) isotype producer,
confirming that IgM/IgD/IgE coexpression is a stable, clonal characteristic of IgE
producers .
Twomodels could explain theobservation ofIgM/IgD/IgE coexpression . All IgE-
producing cells could express IgM/IgD/IgE simultaneously. Alternatively, a small
subset of cells in the sIgM'/sIgD' population might continuously switch VDJ to
t: in a deletionalDNA rearrangement and subsequently express IgE but fail to pro-
FIGURE 3 .
￿
Isotype diversity in
IgE` limiting dilution cultures .
Limiting dilution cultures of
20-2,000
￿
EBVinfected
￿
cells
were tested for Ig secretion after
5 wk . The graph illustratesdata
from IgE' cultures and shows
the proportion of IgE' wells
containing other isotype(s) . Data
from seven limitingdilution ex-
periments are pooled . IgE plus :
(" ) IgM ; (M) IgD ; (0) IgG ;
(7) IgA; (O) IgG + IgA .41 6
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FIGURE 4 . Sublining and cloning of
IgE' limiting dilution cultures . 18 of 79
IgE' limiting dilution cultures were ex-
panded in culture for 3 wk . Nine were sub-
lined at least twice and cells from two such
lines were then formally cloned by limiting
dilution . All cultures were analyzed for the
presence of other Ig isotypes and the per-
cent of cultures expressing a given isotype
in addition to IgE were detected . IgE plus :
(0) IgM ; (N) IgD ; (0) IgG ; (7q) IgA;
([:]) IgG + IgA .
liferate efficiently and form a distinct subpopulation . To distinguish between these
two possibilities, IgE-secreting clones were stained for surface IgM and autocloned
into two populations (brightly or weakly/nonstaining) . One would predict that if
a small, switching subset deleted i and no longer expressed IgM, then some culture
wells would only be positive for IgE . However, subclones in both sorted populations
all coproduced IgM and IgE (Table II) . No secretion was detected in growth-negative
wells . It was interesting to note that the cloning efficiency was much higher in cells
sorted for high expression of sIgM, perhaps reflective ofan activating effect of anti-/
itself. Since all clones expressed FcERs (data not shown), autocloning on the basis
of sIgE expression was not attempted as we were unable to formally distinguish sur-
face from cytophilic IgE .
In the cloning experiments described above, the amount of IgE produced varied
little from well to well, suggesting that all wells contained similar numbers of cells
secreting IgE . After expansion of subclones, the accumulation of secreted IgM and
IgE in culture was quantitated over a 24-h period with the cells in log phase growth .
The amount of 19S IgM secreted was approximately fivefold that of 7S IgE secreted
by the same cell. Assuming similar detection sensitivity in our ELISA for both forms,
and that five monomers of 7S IgM make up one 19S pentamer, this implies that
IgM and IgE are produced at nearly equal rates . This supported results of cloning
data and we believe that the IgE production observed is unlikely due to a small cell
population continuously switching to E .
Characteristics ofIgE Expression .
￿
We next examined the coexpression of IgM and
IgE at the level ofmRNA . Cycloheximide stabilizes some RNA species, including
E (e.g ., 56 and unpublished observation), and we added this drug 12 h beforeRNA
TABLE II
Isotypes Secreted by Clones Selectedfor Surface IgM
IgE-secreting lines were stained with anti-IgM and autocloned. Bright cells
represented 8% of those sorted and weak cells the remainder . Fifth-week clon-
ing cultures were examined for Ig secretion . Representative data from one of
two experiments are presented .
Growing cultures secreting each isotype
Isotype secreted sIgM' (bright) sIgM' - (weak)
IgM or IgE 0:109 0:22
IgM and IgE 109:109 22:22MACKENZIE AND DOSCH
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FIGURE 5 .
￿
Northern blot analysis of mRNA from IgE/M/D-
producing subclones of8G9 . (A) Hybridized with the Ce probe :
(a) U266 myeloma RNA; (b) 8G9 . (B) Hybridized with the Cp
probe; (a) U266 ; (b) 8G9 .
extraction . Poly(A)' mRNA was separated in formaldehyde gels and blotted onto
nitrocellulose . Sequential hybridizations with genomie Ce andCU . probes indicated
the presence of both iA- ande-mRNA species of approximately equal size (Fig . 5) .
RNA from U266, simultaneously probed, did not contain u sequences but it con-
tained amajor specieshybridizingto thee probein a similiar-sized band as observed
inRNA from IgE-producingB cell lines. Faint additional bands hybridizing to the
e probe were present only in U266 RNA and RNAs coding for IgG or IgA were
detected only in IgG- or IgA-producing (control) lines, but not in any of the IgE-
producing cells (data not shown) .
Thecytoplasmic expression ofIgM, IgD, and IgEprotein was examined at a single
cell level by double-fluorescence staining (Fig. 6) . Cytosmears were fixed and suc-
cessively stained with combinations of fluorescein- and rhodamine-conjugated anti-
bodies . About half the cells stained brightly for cIgM (Table III) . Using polyclonal
and monoclonal anti-IgE reagents with similar results, 60-70% of brightly stained
cIgM+ cells also stained brightly for cIgE . No cIgE+ cells were cIgM - , most c1gD+
cells were cIgE+ , and 60-70% of cIgM` cells also expressed c1gD. The latter is
comparable with cIgM+/cIgD+ cells in a control B cell line (clone 34.3), which
produces both IgM and IgD but not IgE. Cytoplasmic IgE but not IgM or IgD
was detected in the U266 myeloma line, which secretes only IgE. Thus, single cells
of IgE-secreting clones express IgM/D and IgE concurrently .
DNA Rearrangements in IgE-producing Lines.
￿
Triple isotype-producing cells could
be explained by failures of allelic exclusion where IgE and IgM/IgD are transcribed
from two active chromosomes . Alternatively, one allele could be transcribed from
VDJ-Ctt through to Cc- (Fig . 7, top) followed by post- transcriptional alternative pro-
cessing into mRNA, generating A, b, and e species (48-51) . To examine the state
and stability of rearrangement patterns, we repeatedly analyzed rearrangements of
the Ig H chain gene region in a series of lines.
Southern blots ofDNA were sequentially hybridized with genomicprobes foreach
Ig class with consistent results . Germline DNA from the original B cell donor and
at least one unrelated donor served as controls to distinguish changes in restriction
fragment size due to rearrangements or polymorphisms . Several subclones were ex-
amined in parallel to examine the stability of transformed IgE producers . Each sub-
clone showed identical patterns in all digests, and on at least two occasions, 6-9 mo
apart .
Fig. 8 shows Barn H1-digested DNA of two subclones of the IgE-secreting line41 8
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FIGURE 6 .
￿
Immunofluorescence of double staining for cytoplasmic IgM and IgE. 106 cells
(>95fo viable) were fixed on a slide and stained with affinity-purified FITC, goat anti-human
IgE (A) and Rhodamine, goat anti-human IgM (B) .
8G9, hybridized first with a Cp probe, then with a probe containing all six of the
J(H) region genes (see Fig. 7) . TworearrangedJ(H) bands were detected . As predicted
by the secretory pattern of IgM production, aVDJ has rearranged to CI, with a
change in restriction fragment length from 19 kb (germline) to 28 kb. The second
TABLE III
Immunqfluorescent Double Staining of IgE-producing Clones
Cells were stained as in Fig . 6 or with FITC goat anti-human IgD instead
ofIgE. Monoclonal anti-IgE, to confirm specificity, was visualized with FITC
goat anti-mouse IgG. U266 is a human IgE-secreting myeloma line . DT1 .2
is a human T-Thybridoma line . The 34 .3 line is an EBV-transformed fetal
B cell that coproduces IgM/IgD but notIgE. 1G7 and 8G9 are IgM/IgD/IgE
coproducing clones .
* Affinity-purified goat anti-human IgE.
" Monoclonal mouse anti-human IgE.
Percentage of cIgM' cells that are also clgE' .
II Percentage of cIgM' cells that are also clgD' .
1 Cytoplasmic IgE' only .
Clone cIgM
IgM/IgE*
m'/E'§ cIgM
IgM/IBEX
M'/E'§ cIgM
IgM/IgD
M'/D' II
1G7 43 70 30 42 45 68
8G9 35 61 28 40 34 65
34 .3 41 0 ND ND 43 71
U266 0 >90, 0 >90, ND ND
DT1 .2 0 0 0 0 0 0MACKENZIE AND DOSCH
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FIGURE 7 .
￿
(Top) Physical map of the human Ig H chain gene locus (not to scale). This order
was constructed according to the findings of several groups (48, 68, 69, 72) based on sequence
data and utilizing information from donors with specific deletions in theIgH locus . (Bottom) Re-
strictionmap ofthe region from J(H) to 6 determined using overlapping phage clones andDNA
sequencing (69) . (t) Barn HI ; (1) Eco RI.
J(H) (20.5-kb fragment) has been assigned to a rearranged Cy (not shown), and
we are presentlydeterminingthe subclass assignment using specific oligonucleotide
probes . Preliminary data indicate a nonproductive VDJ-Cy rearrangement to C-y3
or Cyl .
As shown in Fig . 9, both Cal and Cat genes, as well as CS, are present in germ-
line configuration and are nonrearranged . That Bam HI digests are capable of de-
tecting rearrangements has been previously determined in this and other laborato-
ries (35-37 and unpublished observations) using IgG- or IgA-secreting lines .
The configuration of E loci was examined by hybridization of several restriction
enzymeDNA digests with the E probe (see restriction maps in Fig . 10) (20, 57-59) .
The Barn HI digest demonstrates the retention of all three E germline genes (Fig .
11 A) . This enzyme does not detect CE rearrangements, even in U266 . However,
hybridizations ofXba I digests ofDNA from all our transformed lines show germ-
line configuration of both the coding CE gene region and pet on chromosome 14
(Fig . 11 B) . The U266 IgE-secreting myeloma line has rearranged the functional
CE gene and, as predicted from the genomic map, it has deleted tpEI (Fig . 11 B, lane
b) (20) . The restriction map of (PE2 (on chromosome 9) is not fully known and this
pseudogene is usually not detected in Xba I digests. The presence ofSOE2 in the lines
is confirmed by the Barn HI digest (Fig . 11 A) as well as in hybridizations of Hind
III (Fig . 12) and Eco RI-digested DNA (not shown) .
Fig. 12 illustrates Hind III-digestedDNA hybridized with aJ(H) probeand then
rehybridized with an epsilon probe. Resultsconfirmthat all threeE genes are present
and maintained in germline configuration (22 kb for Cc and 1GE1 : 8.9 kb for 02) .
FIGURE 8 .
￿
Southern blot analysis ofDNAfrom e-pro-
ducing clones . 10 jig of DNA was analyzed . Barn Hl
digests were hybridized with the Cli probe in a-c . Barn
Hl digest hybridized with theJ(H) probe ind-f . (a and
f) germlineDNA from the original donor. (b and d)EBV
transformed IgE'/IgM'/IgD'-secreting clone 8G9 :
subclone 1 . (c and e) 8G9, subclone 2.420
￿
HUMAN IgE-COMMITTED B CELLS
FIGURE 9.
￿
Ram HI digests were hybridized with the cS
probe in a-c . Ram HI digests were hybridized with Cal
in d-J. (a and e) EBVtransformed IgE'/IgM'/IgD'-
secreting clone 8G9 : subclone 1 . (b andf) 8G9, subclone
2 . (c and d) Germline DNA from the original donor .
Again, only two rearrangedJ(H) bands are found (26 and 5.6 kb) and neither lines
up with any E region . The Hind III restriction sites map 2 and 0.5 kb upstream
of functional and pseudoepsilon, respectively, and downstream -0.5 kb 3' of a2
genes in germline DNA (68) .
The Xba I digest confirms germline configuration of functional E as far as 10.5
kb 5' of Ce exon 1 in the C'y4-E intron (Fig . 10) . This includes a stretch ofDNA
>7 kb upstream of the E switch region . A similiar situation is seen with 1GE,, which
is present in germline configuration on a stretch ofDNA at least 5 kb upstream of
its first exon . Downstream both E genes were mapped on Hind III digests to include
Cat and Cat, respectively, in expected (germline) position indicating that both the
CE-a2 and the 1GEt-at intron/exon regions are maintained in germline configuration
(Fig . 12 and not shown) .
Full-length sequencing of the IgH locus may be required to formally determine
if the entire region between VDJ-Cit and CE remains intact . However, the fact that
only twoJ(H) bands were detected as¢ociated with CA on the expressed allele and
C-y on the other, as well as the presence of a 10.5-kb germline DNA region 5' of
E, which includes switch, all suggest that the bulk ofDNA may be retained between
VDJ- l-t and CE on the expressed allele . The presence of germline OEi and Cat bands
at a density equal to CE and Cat bands suggests that all are present and intact on
both alleles and that no major deletions have occurred on the functional allele . Given
the presence of E mRNA, we canr)ot deny that aV region gene is influencing E in
some manner but a lack ofVDJ rearrangement to CE makes even a model of allelic
inclusion unlikely. We orginally suspected that a very large primary nRNA tran-
script was alternatively processed to yield t and E species but alternative mecha-
nisms may have brought a V region gene closer to functional E .
SimilarDNA organizational patterns with rearrangements ofVDJ to C/A and reten-
tion of all E genes in germline configuration were consistently observed in all our
IgE-producing lines. We,therefore concluded that, regardless ofthe precise mechanics,
yVE i FIGURE 10 .
￿
Restriction maps of' the human e
genes and of the expressed c in U266 constructed
by combining reported maps (49, 58, 59) .
Hatched boxes represent exon regions of IgE H
chain constant regions. The e switch region is ti2
kb 5' of the first E exon. (T) Ram HI ; (1) Xba 1 .
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FIGURE 11 .
￿
Southern blot anal-
ysis ofDNA from e-producing
transformants and the U266 my-
eloma line . 10 jig ofDNA were
analyzed . (A) Bam HI digests
hybridizedwith the e probe . (a)
EBVtransformed IgE'/IgM* /
IgD*-secreting clone 8G9 : sub-
clone 1 . (b) 8G9, subclone 2 ; (c)
germlineDNA from the origi-
nal donor. (B) Xba I digests hy-
bridized with the e probe. (a)
Germline DNA from the donor
of 8G9 and 51310 clones . (b)
U266 ; (c) 8G9 : subclone 1 ; (d)
EBVtransformed IgE*/IgM*/
IgD*-secreting clone 51310; (e)
EBVtransformed IgE*/IgM*/
IgD* -secreting clone 2442-
lOC . Germline from the donor
of 2442-IOC was included on
the blot (not shown).
this pattern of gene expression is not a rare exception but represents the typical,
clonally stable characteristic ofIgE-producingB lymphoid cells . As well, ourfindings
indicate that ifDNA rearrangements occur in IgE-producing human B cells, they
do not conform with classical deletional patterns, where VDJ(H) regions utilize
identified switch regions just upstream of the first coding exon . The absence ofnon-
typical patterns in cells secreting any of the IgG or IgA subclasses (e.g ., 36, 38) dis-
tinctly sets the IgE-committed B cell sublineage apart from the vast majority of all
human B lymphocytes .
Discussion
In the present report we describe the subset of normal, human B cells committed
to IgE production . It is characterized by (a) the expression ofIgM and IgD on the
surface ; (b) stable secretion of IgM, IgD, and IgE after activation by EBV in lim-
FIGURE 12 .
￿
Southern blot analysis ofDNA from e-produc-
ing clones and lines. 10 ttg of DNA were analyzed . (A)
Hind III-digested DNA hybridized with the J(H) probe ;
(a) germlineDNA from the donor of8G9 subclones (IgE*/
IgM'/IgD* ) ; (b) 8G9 : subclone 1 ; (c) 8G9, subclone 2 . (B)
Hind III-digested DNA hybridized with the e probe ; (a)
8G9 : subclone 1 ; (b) 8G9, subclone 2 ; (c) germline DNA
from the donor of 8G9 subclones .422
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iting dilution cultures; (c) EBV transformability; (d) continued triple isotype secre-
tion in progeny cells and subclones; (e) coexpression of cIgM, cIgE, and cIgD in
the cytoplasm of single cells; (f) rearrangement of VDJ to Cp. on the active chromo-
some; (g) absence of classical deletionel rearrangements with retention, in germline
configuration, of all three IgE gene loci; and (h) the presence of normal-length IgE
and IgM mRNA species.
The recently described IgE-secreting line, K1D5, was created from similar lim-
iting dilution cultures that permit the outgrowth of low frequency precursors (3,
18, 19). This line secreted not only IgE, but also IgM. Since clonal IgG- and IgA-
secreting lines from the same and many other experiments in our and other labora-
tories (35, 37) never showed coexpression of IgM, we wondered if IgE-committed
B cells were somehow different from B cells committed to other isotypes of the sec-
ondary response. The experiments presented here extend our initial observation by
defining this subset among fresh B cells, following its development at functional,
phenotypic, and molecular levels through activation, transformation, and eventual
cloning. All IgE-committed cells examined continued to coexpress t,, 6, and e
throughout this process. No evidence was obtained for the presence ofclassical dele-
tional switch rearrangements to CE, setting this subset apart from cells expressing
other isotypes 3' of C6.
All isotypes may have the capability to coproduce IgM/IgD and another isotype.
Herzenberg et al. (29) proposed a model whereby cells activated to an `early' memory
B cell stage transiently produce sIgM, sIgD, and sIgG and rapidly lose sIgM and
sIgD expression in a'late' memory B cell stage. Yaoita et al. (23) suggested as well
that such coexpression is transient and is an essential precursor to deletional switch.
This model may explain the presence of rare multiple isotype-positive cells (31). Al-
though we do not detect such cells in purified human IgG+ or IgA+ populations
(36), these cells could have previously moved through this stage. These cells may
be inherently infrequent or difficult to detect because the transition period is very
short. Alternatively, such cells may be EBV resistant or EBV infection may promote
a deletional switch. However, even if all isotypes go through this stage, then IgE
producers do so much less transiently. They may perhaps require more or different
signals for a transition from an earlier to a later, switched B cell stage.
In an alternative model, the deletional switch from VDJ-p, to VDJ-c is an un-
common event, while deletional switch is the rule only for y and a subclasses. Rather
than rare cells frozen in a transitional stage of differentiation, the IgE-producing
cells described here may be the typical IgE-committed B cells. In atopic patients
B cells are found in circulation that secrete IgE spontaneously and at a high rate,
without activation by EBV (12, 13). Current limiting dilution, as well as sorting ex-
periments in our laboratory, indicate that these cells continue to express IgM and
IgD, supporting our view that cellscommitted to IgE production do not frequently
switch but may produce IgE by RNA-processing mechanisms similar to coproduc-
tion of IgM and IgD (Cheema, A ., T. McKenzie, and H.-M. Dosch, manuscript
in preparation). The size of such primary transcripts is not known. In this model,
myeloma lines such as U266 would be examples of rare terminally differentiated
(switched) IgE-producing B cells.
It is conceivable that activation by EBV in our system is generally biased toward
cells that coproduce IgM, IgD, and IgE rather than those that express only IgE.MACKENZIE AND DOSCH
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We believe this to be unlikely since frequencies ofIgE-committed cells stimulated
in the presence ofalloreactive T cell clones were similar to those observed by us with
EBV indicating that the majority of such cells were being detected in either system
(2) . If there was a specific bias, one might expect to detect double or triple isotype-
secreting cells of other Ig classes . We have not observed IgG or IgA secretors in cul-
tures selected for presence ofsIgM or sIgD, nor have we or others (35-37) observed
IgM secretion in IgG- or IgA-producing clones . Cytophilic IgE on IgM producers
may have biased sorting experiments (60) . This is not likely relevant in our studies,
since the majority of IgE-secreting cells were in the sIgE- population and very few
crosscontaminating cells were seen in any sorted population . Our data, therefore,
imply that IgE producers are inherently different from IgG- or IgA-committed cells
and, even if multiple isotype expression (such as IgM/IgD/IgG) occurs in other iso-
types, the frequency and stability of triple isotype-secreting IgE-committed cells
must be much higher.
Supportive evidence that deletional switch is not a priori required for IgE secre-
tion comes from studies of murine lines that spontaneously switch in vitro. Sub-
clones of two IgG2a-secretingmousehybridomas independently began secreting IgE
and ceased IgG2a production without changing DNA restriction endonuclease pat-
terns as determined by Southern blotting (29) . Subclones thathad switched to other
isotypes had almost invariably deleted theC(H) gene coding for the original isotype
and none showed retention of the parent configuration .
If IgE producers do not formally switchVDJ to e, why then does E have a 5' switch
region that seems to be functional, as evident in myeloma lines like U266 (20) . Sug-
gestions that rearrangements would be uncommon because of switch region homology
with Cit switch or because of their position on the chromosome have largely been
discounted (61) . Signals required for the initiation of IgE transcription irf IgM' /
IgD + -unstimulated cells may be similar to those that are responsible for transitory
coproduction of IgG and IgA with IgM . However, signals causing the latter cells
to switch and delete intervening DNA, seem to be missing in or ignored by IgE-
committed B cells .
We propose that switch to e is under stringent control at the molecular level of
the B cell . This control mechanism could, however, be susceptible to external (per-
haps T cell-mediated) triggers . It is possible that, in vivo, switched IgE-secreting
cells aremorecommon and lead to high IgE levels in atopic patients . This presently
seems less likely since at least the bulk of(circulating) IgE producers in such patients
appear to express IgM and IgD as well (see above) . However, the cells responsible
for antigen-specific IgE secretion in atopics have not been examined as yet .
Delayed or infrequent switch has implications for affinity selection during switch
and for the preferential expansion of high affinity clones (61) . Since IgE is poten-
tially a harmful molecule, the absence of switch rearrangements could act as a safe-
guard by reducing the number of high affinity clones and diluting the effectiveness
of the overall IgE response . The concurrent presence of IgM/IgD antibody of the
same specificity would further reduce the functional role of IgE through competi-
tion for allergen . In conditions where IgE is potentially helpful, as during parasitic
infections, it will be interesting to determine if localized B cells secreting IgE have
switched, perhaps in response to specific factors elaborated during the infection .
Coexpression patterns ofIgM/IgD/IgE were clonally stable at both the secretory424
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and molecular level in repeated analysis throughout aperiod of >1 yr. As far as anal-
ysis of both chromosomes is possible without allelic markers, it appeared that the
single remaining CS and both copies of Cal, Cat, CE, and both V'Es remained in
germline configuration and no new rearrangements or deletions were evident (see
Fig. 7) . Only rearrangements of VDJ to C/. were detected and, using five different
restriction enzymes, never to CE . The unproductive rearrangement of VDJ to C-y
was recently confirmed to be to C'Y3, using polymerase chain reaction and subclass-
specific oligonucleotides (unpublished).
The hypothesis that a V region gene may have been brought into a region that
is too far upstream of E to be detected by the enzymes used is attractive. However,
using both Xba I (Fig. 11 B) and Eco RI (not shown) digest, the region -10.5 kb
5' of E was found to be in germline configuration, including a 7.5-kb DNA stretch
upstream of the E switch region. More importantly, we can assign each of the only
two J(H) bands detected to a fragment containing either a rearranged CP, or Cy.
In Eco RI digests theseJ(H) bands (28 and 9.6 kb) do not contain an E gene, and
functional E is detected as a (germline) 35-kb band in Eco RI digests (not shown).
Nevertheless, the production of both 1A and E mRNA species indicates that some
mechanism is controlling coexpression of V and E. Although not a classical dele-
tional rearrangement, some othermechanism maydetermine that E is preferentially
transcribed with /, and 6.
Differential RNA processing of a large primary transcript has been suggested in
anumber of systems to account for coexpression of two products that share genetic
precursors, for example, for the coproduction of IgM and IgD (62). In the mouse
BCLi B2 line, coexpression of IgM and IgG1 was found to be controlled exclusively
at theRNA level (63). Formal proofthat such mechanisms are responsible for coex-
pression of 1., 6, and E requires the isolation of a primary transcript that includes
all three gene regions. If no deletion or manipulation of intervening DNA has oc-
curred then this transcript would be very large (>200 kb) and its detection awaits
improvements in technology.
Alternative mechanisms are conceivable, however. For example, theE exons could
have been brought closer to the Cj,-S region by an inversion mechanism, allowing
fortranscription ofasmall primary transcript. An inversionrequires two breakpoints
but, rather than deleting the intervening DNA, it remains in the chromosome next
to the rearranged segment in inverted form (64). Inversions have been described
in several systems, includingglobin and TCR genes, andthey areespecially common
in Ig gene loci (65, 66).
For example, if DNA from the 5'-E-a2-3' region inverted into a region farther up-
stream, then E would be brought considerably closer to VDJ-/,t, yet all otherC genes
would appear to be in germline configuration. DNA digested with Hind III reveals
a germline 22-kb band (see * in Fig. 12) that hybridizes with both E and a2 . Since
the region between E and a appears to be intact, a2 would have to be included in
such an inversion and there would still be at least 65 kb of DNA to transcribe. In
this model the expressed allele would be transcribed in two directions: 5' VDJ-CU-
C6 3' and 3' Cat-CE 5'. The latter would be read in the direction opposite to its
germline orientation. To accept this model one would have to account for the lack
of functional expression of the intervening Cat and explain how a functional IgE
molecule were to be constructed from theinverted andcomplementary DNA strand.MACKENZIE AND DOSCH
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One hypothesis that may account for coexpression of three isotypes is that C(H)
genesmight be translocated downstream closer to e in anonclassical recombination,
i.e., without using recognized switch sequences. If one assumes that the productive
allele contains only Cj, CS, CE, and Cat, then every other C(H) gene should be
present in only one copy, on the other allele. However, the densities on Southern
blots between e and lei and between a1 and a2 do not appear different, thus not
providing evidence for fewer copies of Oe1 and a1 genes. Thus, a translocation on
the functional chromosome appears unlikely. Karyotypic abnormalities were absent
in our clones.
Duplication of the expressed chromosome as a mechanism accounting for coex-
pression of h and e also seems unlikely. We have found in each of our clones only
two distinct J(H) bands, both of which were nonambiguously assigned to non-e-re-
arranged C(H) regions. A rearrangement arising after the duplication would not
account foreexpression on either allele beyond those mechanisms already discussed.
It is conceivable that a duplication of a functional e gene may have occurred, how-
ever, perhaps by a gene conversion event.
Gene conversion normally involves two closelyrelated genes interacting such that
a portion of the sequence of one gene is converted into the sequence of the other
(67). This seems unlikely as the conversion would have to include an intron region
10.5 kb upstream and 16 kb downstream of e in addition to the 2-kb exon region.
Extensive mapping of germline cosmid clones, switched myelomalines, and fortui-
tous deletions in individuals within the H chain cluster has led to the current con-
struction of the human C(H) gene region (Fig. 7) (68, 69). This does not formally
rule out that a second functional e gene may be present, perhaps in the unmapped
region between theJ-Cu-CS cluster and C'Y3. A mechanism of mRNA processing
of asingle transcript would then involve a smaller, appended region of perhaps <40
kb. However, such a gene would have to either be of equal size to a known e gene
and much of its surrounding intron stretches or be so different that it failed to hy-
bridize to our e probe; both of which seem highly unlikely.
The possibility that unequal crossing over (sister chromatid exchange [SCE]) leads
to e expression may be considered. This mechanism has generally been viewed as
agermline event. However, somatic cells generating switches during SCE can result
in a duplication of the expressed C(H) gene. This may alter the 5' to 3' order of
C(H) genes (and may be one mechanism responsible for inversion) or commit the
cell to production of a particular C(H) gene on the 3' side of deletion (70). It could
therefore account for expression of IgE.
The consistent frequency of IgM/IgD/IgE-secreting cells detected in our system
remains apuzzle sincethe mechanisms considered here are all uncommon. Prelimi-
nary observations in atopic patients suggest that triple isotype a/S/e expression may
be common in vivo. A recent limiting dilution study of mouse IgE-secreting cells
demonstrated that IgE-producing clones secrete IgM and IgE in the same propor-
tions as our clones (N5:1) and are blocked by anti-IgM antibodies, consistent with
the view that IgE expression may follow unique but similar pathways in either spe-
cies (71) . Until approaches such as pulsed field gel electrophoresis provide us with
more information on the order of C(H) genes in our clones, we favor a model of
alternative processing of a single primary transcript, possibly transcribed from a
Cc gene that has been brought closer to the VDJtt-S region and requiring a smaller426
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primary transcript. Whatever the mechanisms responsible for multiple isotype produc-
tion in IgE-committed B cells, our observations seem to rule out classical recombi-
nation/deletion events, such as those seen in the majority of B lineage cells and in
the rare IgE-secreting myeloma lines U266.
In Northern blots of poly(A)+ RNA hybridized with A and E probes, the detec-
tion of E mRNA required a sevenfold longer development period. Levels of it and
E mRNA are therefore markedly different. This dichotomy was also observed in the
BCL1.B2 clone (63) and in cells that coexpress sIgM and sIgD where the level of
p, membrane mRNA is 10 times that of S despite higher levels of membrane IgD
(72). It is possible that transcription of [ is preferentially terminated immediately
3' ofC/A exons and that IgE is expressed as the result of infrequent RNA polymerase
unloading downstream of CE . However, observations in the tc/8 system suggest that
mRNA expression is both translationally and post-translationally regulated (62).
The mRNA species may also have different halflives or be preferentially processed
to A . Indeed, our experiments suggest that E mRNA is less stable and may be spe-
cifically degraded or regulated by a protein, since it is stabilized in the presence
of cycloheximide (unpublished) . If this observation can be confirmed it would sug-
gest that major regulatory events are occurring at post-transcriptional levels. Ex-
periments show as well that IgE and IgM protein are produced at rates that do not
reflect the disparity in mRNA levels. Results of cytoplasmic staining suggested that
the translation or export rate of IgE protein may be more variable than that of IgM
as most cells stain brightly for cIgM, while only 60-70% of these are also brightly
cIgE+ . Characterization of the differential mechanisms controlling IgM and IgE
production could lead to therapeutic strategies for the selective manipulation of IgE
expression. This could represent a powerful tool in the management of atopic disease.
Summary
We have followed the pathway of the IgE-committed B lymphocyte from fresh,
unstimulated peripheral blood, through EBV activation, transformation, and even-
tual cloning. Using cell sorting in conjunction with limiting dilution culture systems,
we found that: (a) cells that are selected in the cell sorter and secrete IgE in culture
are sIgM+/sIgD+ . They secrete all three isotypes after EBV activation and continue
to do so stably in culture; (b) individual IgE+ cells in culture coproduce IgM, IgD,
and IgE and cytoplasmic Ig of each isotype can be detected in single cells; (c) no
rearrangement was observed of VDJ to E in any of six lines tested. DNA between
the rearranged VDJ-p, and -E appears to be overall intact, including a region 10.5
kb upstream and 18 kb downstream of the 2-kb E coding region and; (d) mRNA
of W and E species is of normal and comparable size. In contrast to IgG- and IgA-
producing clones, multiple isotype expression appears to be both frequent and stable
in cells committed to IgE production. We propose that IgE-committed cells repre-
sent a unique B cell sublineage whose differentiation pathway may be more strictly
regulated than thatofother isotypes with regard to the signals required for classical,
deletional switch recombination that has been observed in rare IgE-producing my-
eloma cell lines.
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